Results 151 to 160 of about 16,988,510 (382)

Glycemic Control Status and Long-term Clinical Outcomes in Diabetic Chronic total occlusion patients: An Observational Study [PDF]

, 2021
Xuehui Zhang, Maoxiao Nie, Xue Chen, Zhe Liang, Quanming Zhao   +4 more
openalex   +1 more source

Phosphatidylinositol 4‐kinase as a target of pathogens—friend or foe?

FEBS Letters, EarlyView.
This graphical summary illustrates the roles of phosphatidylinositol 4‐kinases (PI4Ks). PI4Ks regulate key cellular processes and can be hijacked by pathogens, such as viruses, bacteria and parasites, to support their intracellular replication. Their dual role as essential host enzymes and pathogen cofactors makes them promising drug targets.
Ana C. Mendes, Guilherme M. Azevedo, Amanda P. Barcellos, Diana Bahia   +3 more
wiley   +1 more source

Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma

Allergy, Asthma & Clinical Immunology
Background Systemic corticosteroid (SCS) use remains widespread among patients with severe asthma, despite associated complications. Objective Evaluate the association between cumulative SCS exposure and SCS-related complications in severe asthma ...
Thomas B Casale, Thomas Corbridge, Guillaume Germain, François Laliberté, Sean D MacKnight, Julien Boudreau, Mei S Duh, Arijita Deb   +7 more
doaj   +1 more source

PPA1 regulates tumor malignant potential and clinical outcome of colon adenocarcinoma through JNK pathways

, 2017
Ping Wang, Yi Zhou, Qi Mei, Jing Zhao, Liu Huang, Qiang Fu   +5 more
openalex   +2 more sources

Ataxia-telangiectasia: immunologic profile and clinical outcome [PDF]

, 2015
Clarissa De Lima Honório Dumas, Fabíola Scancetti Tavares, Hermínio De Paula Ramos Netto, Vanessa Silva Pereira Campos, Cláudia França Cavalcante Valente, Luciana Lilian Dias Pereira   +5 more
openalex   +1 more source

Comorbidities Burden and Implementation of the Treat–to–Target Strategy in Predicting Real-World Patient Outcomes in Spondyloarthritides

, 2023
Irini Flouri, Argyro Repa, Nestor Avgoustidis, Sofia Pitsigavdaki, K. Pateromichelaki, Eleni Marolachaki, Maria Terizaki, Myrto Nikoloudaki, Anastasios Eskitzis, Eleni Kalogiannaki   +9 more
openalex   +1 more source

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

New England Journal of Medicine, 2016
S. Marso, S. Bain, A. Consoli, F. Eliaschewitz, E. Jódar, Lawrence A Leiter, I. Lingvay, J. Rosenstock, J. Seufert, M. Warren, V. Woo, O. Hansen, A. Holst, Jonas Pettersson, T. Vilsbøll   +14 more
semanticscholar   +1 more source

Structural insights into lacto‐N‐biose I recognition by a family 32 carbohydrate‐binding module from Bifidobacterium bifidum

FEBS Letters, EarlyView.
Bifidobacterium bifidum establishes symbiosis with infants by metabolizing lacto‐N‐biose I (LNB) from human milk oligosaccharides (HMOs). The extracellular multidomain enzyme LnbB drives this process, releasing LNB via its catalytic glycoside hydrolase family 20 (GH20) lacto‐N‐biosidase domain.
Xinzhe Zhang, Naoki Sunagawa, Toma Kashima, Kiyohiko Igarashi, Akimasa Miyanaga, Shinya Fushinobu   +5 more
wiley   +1 more source

Drug prescription clusters in the UK Biobank: An assessment of drug-drug interactions and patient outcomes in a large patient cohort [PDF]

, 2022
Kyriakos Schwarz, Daniel Trejo Baños, Giulia Rathmes, Michael Krauthammer   +3 more
openalex   +1 more source

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

New England Journal of Medicine, 2016
M. Fischereder, U. Schönermarck
semanticscholar   +1 more source